Immune Tolerance in Cancer and Autoimmune Disease

Abcam, Inc.
Last Modified: February 13, 2009

Share article

Conference Dates: May 06 - 09, 2009
Conference Location: Antigua

Sponsoring Group: Abcam, Inc.

Conference Web Page URL:

Conference Objectives: Immune Tolerance in Cancer and Autoimmune Disease: how to break it, and how to (re-)make it.

Conference Agenda: Immune Tolerance in Cancer and Autoimmune Disease: how to break it, and how to (re-)make it.

Registration Information: The fee is fully inclusive of: conference registration and materials, including book of abstracts accommodation for the nights of May 6, 7 and 8 all meals, snacks and unlimited drinks transfers to/from the hotel in Antigua non-motorized water sports Early Bird (by Mar 6, 2009) Standard (by Mar 27, 2009) Single $995 $1195 Twin/Double $895 $995 Student (twin)* $795 $895 Partners ** $450 $500

Continuing Education: Yes

New Cervical Cancer Vaccine Targets HPV-Infected Women

Oct 11, 2012 - A new candidate vaccine designed to prevent cervical dysplasia and cancer in women already infected with human papillomavirus serotypes 16 and 18 is well tolerated and induces a robust immune response, according to a phase 1 study published in the Oct. 10 issue of Science Translational Medicine.

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More